Publications

Cite INHERENT:

Kountouris P, Stephanou C, Archer N, Bonifazi F, Giannuzzi V, Kuo KHM, Maggio A, Makani J, Mañú-Pereira MDM, Michailidou K, Nkya S, Nnodu OE, Trompeter S, Tshilolo L, Wonkam A, Zilfalil BA, Inusa BPD, Kleanthous M; on behalf of the International Hemoglobinopathy Research Network (INHERENT). The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies. Am J Hematol. 2021 Nov 1;96(11):E416-E420. doi: 10.1002/ajh.26323. Epub 2021 Aug 30. PMID: 34406671

 

INHERENT publications

  1. Evangelidis P, Venou TM, Fani B, Vlachaki E, Gavriilaki E; on behalf of the International Hemoglobinopathy Research Network (INHERENT). Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron? Int J Mol Sci. 2023 Nov 13;24(22):16263. doi: 10.3390/ijms242216263. PMID: 38003451
  2. Traeger-Synodinos J, Vrettou C, Sofocleous C, Zurlo M, Finotti A, Gambari R; International Hemoglobinopathy Research Network (INHERENT). Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management. Int J Mol Sci. 2024 Mar 17;25(6):3400. doi: 10.3390/ijms25063400. PMID: 38542374
  3. Gambari R, Waziri AD, Goonasekera H, Peprah E. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications. Int J Mol Sci. 2024 Apr 12;25(8):4263. doi: 10.3390/ijms25084263. PMID: 38673849.
  4. Chatzidavid S, Flevari P, Tombrou I, Anastasiadis G, Dimopoulou M; International Hemoglobinopathy Research Network (INHERENT). Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology. Int J Mol Sci. 2024 Apr 27;25(9):4792. doi: 10.3390/ijms25094792. PMID: 38732015.
  5. Labarque V, Okocha EC; International Hemoglobinopathy Research Network (INHERENT). Systematic Review of Genetic Modifiers Associated with the Development and/or Progression of Nephropathy in Patients with Sickle Cell Disease. Int J Mol Sci. 2024 May 16;25(10):5427. doi: 10.3390/ijms25105427. PMID: 38791464.
  6. Oni MO, Brito M, Rotman C, Archer NM; International Hemoglobinopathy Research Network (INHERENT). Genetic Modifiers of Stroke in Patients with Sickle Cell Disease – A Scoping Review. Int J Mol Sci. 2024 Jun 7;25(12):6317. doi: 10.3390/ijms25126317. PMID: 38928024.
  7. Harteveld CL, Achour A, Fairuz Mohd Hasan NF, Legebeke J, Arkesteijn SJG, Huurne JT, Verschuren M, Bhagwandien-Bisoen S, Schaap R, Vijfhuizen L, Idrissi HE, Babbs C, Higgs DR, Koopmann TT, Vrettou C, Traeger-Synodinos J, Baas F; International Hemoglobinopathy Research Network (INHERENT). Loss-of-Function Variants in SUPT5H as Modifying Factors in Beta-Thalassemia. Int J Mol Sci. 2024 Aug 16;25(16):8928. doi: 10.3390/ijms25168928. PMID: 39201615.
  8. Stephanou C, Menzel S, Philipsen S, Kountouris P; International Hemoglobinopathy Research Network (INHERENT). Genetic Polymorphisms Associated with Fetal Hemoglobin (HbF) Levels and F-Cell Numbers: A Systematic Review of Genome-Wide Association Studies. Int J Mol Sci. 2024;25(21):11408. Published 2024 Oct 23. doi:10.3390/ijms252111408. PMID: 39518961
  9. Diamantidis MD, Ikonomou G, Argyrakouli I, Pantelidou D, Delicou S; International Hemoglobinopathy Research Network (INHERENT). Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease. Int J Mol Sci. 2024;25(22):11886. Published 2024 Nov 5. doi:10.3390/ijms252211886. PMID: 39595957